Radiation Therapy With Monoclonal Antibodies

Warnings about serious side effects of ibritumomab (Zevalin) have been issued by the U.S. Food and Drug Administration (FDA). Some of these side effects have been fatal. These side effects include trouble breathing; closing of the throat; swollen lips, tongue, or face; heart problems; and severe skin reactions. If you develop any of these symptoms, contact your doctor immediately.

Ibritumomab and tositumomab may cause birth defects. Do not receive this therapy if you are pregnant or if you wish to become pregnant or father a child while you are taking these medicines.

Serious side effects of ibritumomab and tositumomab may include:

• Blood disorders and Reference leukemia Opens New Window.
• Reduced production of Reference bone marrow Opens New Window.
• Reference Hypothyroidism Opens New Window.

Less serious side effects may include:

• Abdominal pain.
• Chills.
• Fatigue.
• Fever.
• Infection.
• Muscle or joint pain.
• Nausea or vomiting.
• Rashes.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.